Dr. Faris A. Khasawneh, MD

Dr. Khasawneh practices at Northwestern Medicine Palos Hospital in Palos Heights, Illinois, part of Northwestern Memorial HealthCare.

Dr. Khasawneh's NPI, 1831374594, was assigned on December 31, 2007. Dr. Khasawneh holds Illinois license 036117597.

Dr. Khasawneh's primary practice is Northwestern Medicine Palos Hospital, at 12251 South 80th Avenue, Palos Heights, IL 60463 in Cook County. The practice phone is (708) 923-4000.

Dr. Khasawneh's primary practice is Northwestern Medicine Palos Hospital in Palos Heights, Illinois, part of Northwestern Memorial HealthCare. The medical group on file is Northwestern Medicine Regional Medical Group. Dmand AI also links Dr. Khasawneh to 5 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khasawneh practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Khasawneh's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Khasawneh's licenses on file in 2 states: Illinois and Kentucky.

CMS data shows 949 Medicare services from Dr. Khasawneh across 5 procedure codes in 2024, for 383 Medicare patients. Medicare paid $90,374 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 383 Medicare patients who saw Dr. Khasawneh in 2024. The largest group is 75 to 84, with 147 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khasawneh's median patient age at 72, with 51% women.

In 2024, Dr. Khasawneh wrote 371 Medicare Part D claims for 146 patients. 87% of them were for generic drugs. CMS names the drug for 131 of them, across 8 drugs with 11 or more claims each, at $12,572 in total drug cost. In 2023, CMS named 229 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Khasawneh for performance year 2024, reported through an alternative payment model (APM). Dr. Khasawneh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Khasawneh from 2 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Edwards Lifesciences Corporation paid the most, $23.